Manuscripts
Showing 1533 manuscripts.
Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.
Citation
Kathleen Malee, Paige L. Williams, Grace Montepiedra, Sharon L. Nichols, Patricia Sirois, Deborah S. Storm, John J. Farley, Betsy Kammerer. Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.. AIDS Patient Care and STDs. 2011. 25: 191-200. PMID: 21323533Year
2011
Journal
AIDS Patient Care and STDs
Low rate of birth defects among infants born to HIV-infected women on antiretrovirals
Citation
Heather D. Watts, Sharon Huang, Mary Culnane, Kathleen A. Kaiser, Angela Scheuerle, Lynne M. Mofenson, Kenneth Stanley, Marie Louise Newell, Laurent Mandelbrot, Jean-Francois Delfraissy, Coleen K. Cunningham. Low rate of birth defects among infants born to HIV-infected women on antiretrovirals. Journal of Perinatal Medicine. 2011. 39: 163-170. PMID: 21142844Year
2011
Journal
Journal of Perinatal Medicine
Psychological Factors, Beliefs About Medication, and Adherence of Youth with HIV-1 in a Multisite Directly Observed Therapy (DOT) Pilot Study
Citation
Patricia A. Garvie, Patricia M. Flynn, Marvin Eric Belzer, Paula Britto, ChengCheng Hu, Bobbie L. Graham, Michael N. Neely, George D. McSherry, Stephen A. Spector, Aditya Gaur. Psychological Factors, Beliefs About Medication, and Adherence of Youth with HIV-1 in a Multisite Directly Observed Therapy (DOT) Pilot Study. Journal of Adolescent Health. 2011. 48: 637-640. PMID: 21575827Year
2011
Journal
Journal of Adolescent Health
Study
P1036B
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.
Citation
Ronald J. Bosch. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.. Journal of Interferon and Cytokine Research. 2011. 31: 481-3. PMID: 21291323Year
2011
Journal
Journal of Interferon and Cytokine Research
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362
Citation
Susan Ellen Cohn, Hongyu Jiang, J. Allen McCutchan, Susan L. Koletar, Robert L. Murphy, Kevin R. Robertson, Annabelle de St. Maurice, Judith Silverstein Currier, Paige L. Williams. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care. 2011. 23: 775-85. PMID: 21293986Year
2011
Journal
AIDS Care
Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.
Citation
Giovanni Schifitto. Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.. Journal of Neurovirology. 2011. 17: 17-25. PMID: 21181521Year
2011
Journal
Journal of Neurovirology
The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort
Citation
Benjamin P. Linas, Bingxia Wang, Marlene Smurzynski, Elena Losina, Ronald J. Bosch, Bruce R. Schackman, Jian Rong, Paul Edward Sax, Rochelle Paula Walensky, Jeffrey T. Schouten, Kenneth A. Freedberg. The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. Journal of Viral Hepatitis. 2011. 18: 506-12. PMID: 20546501Year
2011
Journal
Journal of Viral Hepatitis
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
Citation
Andrea L. Ciaranello, Shahin Lockman, Kenneth A. Freedberg, Michael Hughes, Jennifer Chu, Judith Silverstein Currier, Robin Wood, Charles Holmes, Sandy Pillay, Francesca Conradie, James Alasdair McIntyre, Elena Losina, Rochelle Paula Walensky. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011. 25: 479-92. PMID: 21293199Year
2011
Journal
AIDS
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.
Citation
Susan Swindells, Hongyu Jiang, Lisa Mukherjee, Mark A. Winters, Ronald J. Bosch, David Katzenstein. Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.. HIV Clinical Trials. 2011. 12: 79-88. PMID: 21498151Year
2011
Journal
HIV Clinical Trials
Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection
Citation
Elizabeth Connick, Ronald J. Bosch, Evgenia Aga, Rick Schlichtemeier, Lisa M. Demeter, Paul Volberding. Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection. Journal of Acquired Immune Deficiency Syndromes. 2011. 58: 1-8. PMID: 21637110Year
2011
Journal
Journal of Acquired Immune Deficiency Syndromes